Sodium/glucose cotransporter 2: Difference between revisions

Created page with "{{Short description|Protein-coding gene in the species Homo sapiens}} {{Infobox gene}} The '''sodium/glucose cotransporter 2''' (SGLT2) is a protein that in humans is encoded by the {{gene|SLC5A2}} (solute carrier family 5 (sodium/glucose cotransporter)) gene. == Function == SGLT2 is a member of the sodium glucose cotransporter family, which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransport..."
 
Marked this version for translation
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
<languages />
<translate>
<!--T:1-->
{{Short description|Protein-coding gene in the species Homo sapiens}}
{{Short description|Protein-coding gene in the species Homo sapiens}}
{{Infobox gene}}
{{Infobox gene}}


<!--T:2-->
The '''sodium/glucose cotransporter 2''' (SGLT2) is a [[protein]] that in humans is encoded by the {{gene|SLC5A2}} (solute carrier family 5 (sodium/glucose cotransporter)) [[gene]].
The '''sodium/glucose cotransporter 2''' (SGLT2) is a [[protein]] that in humans is encoded by the {{gene|SLC5A2}} (solute carrier family 5 (sodium/glucose cotransporter)) [[gene]].


== Function ==
== Function == <!--T:3-->
SGLT2 is a member of the [[sodium-glucose transport proteins|sodium glucose cotransporter family]], which are sodium-dependent [[glucose]] transport proteins. SGLT2 is the major cotransporter involved in glucose [[reabsorption]] in the kidney.  SGLT2 is located in the early [[proximal tubule]], and is responsible for reabsorption of 80-90% of the glucose filtered by the kidney [[Glomerulus (kidney)|glomerulus]]. Most of the remaining glucose absorption is by [[sodium/glucose cotransporter 1]] (SGLT1) in more distal sections of the proximal tubule.
SGLT2 is a member of the [[sodium-glucose transport proteins|sodium glucose cotransporter family]], which are sodium-dependent [[glucose]] transport proteins. SGLT2 is the major cotransporter involved in glucose [[reabsorption]] in the kidney.  SGLT2 is located in the early [[proximal tubule]], and is responsible for reabsorption of 80-90% of the glucose filtered by the kidney [[Glomerulus (kidney)|glomerulus]]. Most of the remaining glucose absorption is by [[sodium/glucose cotransporter 1]] (SGLT1) in more distal sections of the proximal tubule.


== SGLT2 inhibitors for diabetes ==
== SGLT2 inhibitors for diabetes == <!--T:4-->
{{Main|SGLT2 inhibitor}}
{{Main|SGLT2 inhibitor}}
[[SGLT2 inhibitor]]s are also called gliflozins or flozins. They lead to a reduction in blood glucose levels, and therefore have potential use in the treatment of [[type 2 diabetes]]. Gliflozins enhance glycemic control as well as reduce [[Human body weight|body weight]] and systolic and diastolic [[blood pressure]]. The gliflozins canagliflozin, dapagliflozin, and empagliflozin may lead to euglycemic [[ketoacidosis]]. Other side effects of gliflozins include increased risk of Fournier gangrene
[[SGLT2 inhibitor]]s are also called gliflozins or flozins. They lead to a reduction in blood glucose levels, and therefore have potential use in the treatment of [[type 2 diabetes]]. Gliflozins enhance glycemic control as well as reduce [[Human body weight|body weight]] and systolic and diastolic [[blood pressure]]. The gliflozins canagliflozin, dapagliflozin, and empagliflozin may lead to euglycemic [[ketoacidosis]]. Other side effects of gliflozins include increased risk of Fournier gangrene


== Clinical significance ==
== Clinical significance == <!--T:5-->


<!--T:6-->
Mutations in this gene are also associated with [[renal glycosuria]].
Mutations in this gene are also associated with [[renal glycosuria]].


== See also ==
== See also == <!--T:7-->
* [[SGLT]] Family
* [[SGLT]] Family
* [[Discovery and development of gliflozins]]
* [[Discovery and development of gliflozins]]
* [[Phlorizin]] — a competitive inhibitor of [[SLC5A1|SGLT1]] and [[SGLT2]]
* [[Phlorizin]] — a competitive inhibitor of [[SLC5A1|SGLT1]] and [[SGLT2]]


== References ==
== References == <!--T:8-->
{{reflist|33em}}
{{reflist|33em}}


== Further reading ==
== Further reading == <!--T:9-->
{{refbegin|33em}}
{{refbegin|33em}}
* {{cite journal | vauthors = van den Heuvel LP, Assink K, Willemsen M, Monnens L | title = Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2) | journal = Human Genetics | volume = 111 | issue = 6 | pages = 544–7 | date = Dec 2002 | pmid = 12436245 | doi = 10.1007/s00439-002-0820-5 | s2cid = 28089635 }}
* {{cite journal | vauthors = van den Heuvel LP, Assink K, Willemsen M, Monnens L | title = Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2) | journal = Human Genetics | volume = 111 | issue = 6 | pages = 544–7 | date = Dec 2002 | pmid = 12436245 | doi = 10.1007/s00439-002-0820-5 | s2cid = 28089635 }}
Line 34: Line 39:
{{refend}}
{{refend}}


<!--T:10-->
{{Solute carrier family|bg|bg0}}
{{Solute carrier family|bg|bg0}}
{{Sodium-glucose transporter modulators}}
{{Sodium-glucose transporter modulators}}
{{二次利用|date=18 December 2023}}
{{二次利用|date=18 December 2023}}


<!--T:11-->
[[Category:Solute carrier family]]
[[Category:Solute carrier family]]
[[Category:Genes mutated in mice]]
[[Category:Genes mutated in mice]]
</translate>